Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02244489
Title Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Scottsdale Healthcare Research Institute Scottsdale Arizona 85258 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field